3Chen M S, Xu F P, Wang Y Z, et al. Staatins initiated after hypertrophy inhibit oxidative stress and prevent heart failure in rats with aortic stenosis[J]. J Mol Cell Cardiol, 2004, 37 (4) : 889.
7Aster E, Bertolami M C, Venturinelli M L, et al. Atorvas tatin reduces pro inflammatory markers in hyperc- holesterolemic patients [ J ]. Atherosclemrosis, 2004, 177 (1): 161.
8Pliquett R U, Cornish K G, Peuler J D, et al. Simvastatin normalizes autonomic neural control in experimental heart failure[J]. Circulation, 2003, 107(19): 2493.
9Node K, Fuiita M, Kitakaze M, et al. Short- term statin theary improves cardiac function and symptoms in patients with idiopathicdilated cardiomyopathy [ J ]. Circulation, 2003, 108(17): 839.
4Pasceri-V, Willerson-J-T, Yeh-E-T. Direct proinfammatory effect of C-reactive protein on human endothelial cells. Circulation, 2000,102 ( 18 ): 2165 -2168.
5Biasueei-L-M, Collizzi-C, Rizzello-V, et al. Role of inflammation in the pathogenesis of unstable coronary atery disease [ J ]. Scand-J-Clin-Lab-Invest-Suppl, 1999,230 : 12- 22.
6Correia LC, Sposito AC, Lima JC, et al. Antiinflammatory effect of atorvastatin (80mg) in unstable angina pectoris and non-Q-wave acute myocardial infarction [ J ]. Am J Cardiol. 2003,92 (3) :298-301.
7Ostadal P, Alan D, Haijek D, et al. The effect of early treatment by cerivastatin in the serum level of C-reactive protein,interleukin-6 and interleukin-8 in the patients with unstable angina and non-Q-wave myocardial infarction[ J]. Mol Cell Biochen,2003,246 (1-2) :45-50.
8Chyrchel M, Dudek D, Bartus S, et al. High-dose statin and COX-2 inhibitor therapy rapidly decrease C-reactive protein level in patients with unstable angina [ J ]. Kardiol pol,2004,61 (9):213-221.
9Luigi M, Giovanna L, Rita L, et al. Elevated levels of C- reactive protein at discharge in patients with unstable angina predict recurrent instability[J]. Clin Invest Rep, 1998, 11:855-859.
10Folson AR, Aleksic N, Cateller D, et al. C-reactive protein and incident coronary risk in communities (ARIC) study [ J ]. Am Heart J, 2002,144 ( 2 ) : 233-237.
3Steven E. Nissen,Stephen J. Nicholls,Ilks Sipahi,Peter Libby,Joel S. Raichlen,Christie M. Ballantyne,Jean Davignon,Raimund Erbel,Jean Charles Fruchart,Jean-Claude Tardif,Paul Schoenhagen,Tim Crowe,Valerie Cain,Kathy Wolski,Marlene Coormastic,E. Murat Tuzcu,仝其广（译）,王淑敏（译）,胡大一（校）.极高强度他汀治疗对冠状动脉粥样硬化消退的影响——ASTEROID试验[J].美国医学会杂志（中文版）,2006,25(4):215-223. 被引量：346
5Fundam. Disease: the pharmacology of trimetazidine [ J ]. ClinPharmaco, 2003, 17(2): 133.
6Marazzi G, Gebara O, Vitale C, et al. Effect of trimetazi- dine on quality of life in elderly patients with ischerm'cdil.ated cardiomyopathy[J]. Adv Ther, 2009, 26(4): 455.
7Stanton E B, Hansen M S, Sole M J, et al. Cardiac troponin I, a possible predictor of survival in patients with stable con- gestive heart failurel[J]. Can J Cardiol, 2005, 21(1) : 39.
